Please cite this article as: Y. Baradaran-Heravi, C. Van Broeckhoven and J. van der Zee, Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum, Neurobiology of Disease(2018), https://doi.Journal Pre-proof J o u r n a l P r e -p r o o f Baradaran-Heravi et al., 2 ABSTRACT Stress granules (SGs) are dynamic membraneless compartments composed out of RNA -binding proteins (RBPs) and RNA molecules that assemble temporarily to allow the cell to cope with cellular stress by stalling mRNA translation and moving synthesis towards cytoprotective proteins. Aberrant SGs have become prime suspects in the nucleation of toxic protein aggregation in frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). Perturbed SG dynamics appears to be mediated by alterations in RNA binding proteins (RBP). Indeed, a growing number of FTD and/or ALS related RBPs coding genes (TDP43, FUS, EWSR1, TAF15, hnRNPA1, hnRNPA2B1, ATXN2, TIA1) have been identified to interfere with SG formation through mutation of their low-complexity domain (LCD), and thereby cause or influence disease. Interestingly, disease pathways associated to the C9orf72 repeat expansion, the leading genetic cause of the FTD-ALS spectrum, intersect with SG-mediated protein aggregate formation. In this review, we provide a comprehensive overview of known SG proteins and their genetic contribution to the FTD-ALS spectrum. Importantly, multiple LCD-baring RBPs have already been identified in FTD-ALS that have not yet been genetically linked to disease. These should be considered candidate genes and offer opportunities for gene prioritization when mining sequencing data of unresolved FTD and ALS. Further, we zoom into the current understanding of the molecular processes of perturbed RBP function leading to disturbed SG dynamics, RNA metabolism, and pathological inclusions. Finally, we indicate how these gained insights open new avenues for therapeutic strategies targeting phase separation and SG dynamics to reverse pathological protein aggregation and protect against toxicity. Journal Pre-proof J o u r n a l P r e -p r o o f Baradaran-Heravi et al., Sreedharan et al., 2008; Van Langenhove et al., 2010) (Figure 1). RBPs bind to RNAs to form heterogeneous nuclear ribonucleoprotein (hnRNP) complexes and thereby control RNA processing and metabolism (i.e. transcription, RNA splicing, nuclear export, mRNA transport, translation, sequestration and degradation). The majority of neurodegeneration-related RBPs harbor a conserved low complexity domain (LCD), also called prion-like domain. The LCD is the key component that drives (liquid-liquid) phase separation (LLPS) and thereby mediates stress granule (SG) formation (Lee et al., 2016) (Figure 2). SGs are cytoplasmic RNP granules composed of repressed translational complexes and are generated upon cellular stress resulting into dynamic membraneless compartments. SGs allow the cell to cope with Journal Pre-proof J o u r n a l P r e -p r o o f Baradaran-Heravi et al., 4 stress by stalling mRNA translation and moving synthesis towards cytoprotective proteins. They are intrinsically dynamic and dissolve again as the stress passes. SGs have become prime suspects in the nucleation of toxic protein aggregation in FTD and ALS. Most of the disease -causing mutations map to the LCD regions of SG-related RBPs and disrupt their biophysical properties, leading to increased LLPS into SGs and aggregate formation (Kim et al., 2013; Mackenzie et al., 2017; Patel et al., 2015) . SGs formed by these FTD-ALS linked mutant RBPs are impaired in their dynamics and remain insoluble, further trapping wild-type RBPs leading to irreversible, toxic aggregates (Figure 2) .
I. State of the art
Neurodegenerative disorders like frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are pathologically characterized by toxic protein deposition in the cytoplasm of affected neurons. Many of these aggregated proteins belong to the class of RNA binding proteins (RBP) , and, when mutated, account for a significant subset of familial ALS and FTD cases (Kim et al., 2013; Kwiatkowski et al., 2009; Liu et al., 2013; Mackenzie et al., 2017; Vance et al., 2009) . FTD and ALS are both fatal neurodegenerative disorders characterized by progressive atrophy of the frontal and temporal brain regions in FTD, and loss of upper and lower motor neurons in ALS. In 30-50% of FTD patients, the disease is familial and most often inherited in an autosomal dominant manner. Mutations in the microtubuleassociated protein tau (MAPT), granulin (GRN) and chromosome 9 open reading frame 2 (C9orf72) genes represent the most common genetic causes of inherited FTD. In ALS, classic familial inheritance is only observed in 5-10% of the cases (both dominant and recessive), with mutations in the superoxide dismutase 1 (SOD1) gene and C9orf72 being the major causes. Yet even in apparently sporadic FTD and ALS patients, heritability is expected to be high. Clinical signs of both FTD and ALS are regularly observed in the same patient or segregating within families, uniting both disorders into a FTD-ALS (or ALS-FTD) disease spectrum. Whereas MAPT and GRN are exclusive to FTD, and SOD1 to ALS, multiple genes have been associated to the FTD-ALS spectrum, with the C9orf72 repeat expansion as the leading cause in both FTD and ALS. Supporting the clinical and genetic overlap, FTD and ALS are also linked by common pathological signatures with aggregation of the RBPs TAR DNA binding protein (TDP-43) into nuclear and/or cytoplasmic inclusions in near all ALS (97%) and 50% of FTD, and FUS RNA binding protei n (FUS) in a small subset of ALS and FTD patients.
Mutations in a series of RBP genes FUS, TAF15, EWSR1, hnRNPA1, hnRNPA2B1, ATXN2, TIA1) have been identified to cause or influence disease risk for ALS and/or FTD (Couthouis et al., 2012; Elden et al., 2010; Kim et al., 2013; Kwiatkowski et al., 2009; Mackenzie et al., 2017; Neumann et al., 2011;  J o u r n a l P r e -p r o o f mutations affect the Gly-rich LCD, which is responsible for the interaction with other RBPs and mRNA trafficking to distal compartments (Figure 1 ). The LCD also mediates LLPS and recruitment of TDP -43 to SGs. LCD mutations strengthen the aggregation propensity of TDP-43 (Johnson et al., 2009; Nonaka et al., 2009) leading to nuclear depletion, either due to a failed nucleocytoplasmic transport, or, by trapping of wild-type TDP-43 into the SGs formed by mutated TDP-43. The increased accumulation of TDP-43 into SGs impairs their dynamics, promoting further conversion to pathological inclusions (Alami et al., 2014; Dewey et al., 2011; Gopal et al., 2017) (Figure 2 ). Taken together, these different pathways of disrupted RNA metabolism, mRNA transport, reduced SG dynamics and loss of wild-type TDP-43 function, seem to complement each other culminating in neuronal loss (Conicella et al., 2016; Coyne et al., 2014; Johnson et al., 2009; Narayanan et al., 2013) . Importantly, TDP-43 positive protein inclusions are also observed in FTD and ALS patients without a TARDBP mutation, but rather mutations in other genes including GRN, C9orf72, and VCP, which do not belong to the class of RBPs, as well as in patients without a recognized pathogenic mutation.
II.2 FUS, TAF15, EWSR1, and FUS pathology
Following the identification of Fused in sarcoma (FUS), related proteins TATA box -binding proteinassociated factor 15 (TAF15) and Ewing's sarcoma breakpoint region 1 (EWSR1) were found to coaggregate with FUS in the inclusions of FTD-FUS patients, later renamed as FTD-FET (with inclusions constituting a family of RBPs named FET) (Neumann et al., 2011) . In contrast, this co-aggregation appeared to be absent in ALS-FUS, suggesting FUS dysfunction as the leading cause of disease (Neumann et al., 2011) .
Mutations in the FUS gene were found to cosegregate in multiple autosomal dominant families with ALS. Currently, over 50 mutations (missense and few in-frame deletions) have been reported explaining up to 5% of fALS and less than 1% sALS patients, which is comparable to frequencies estimated for TARDBP. The most common ALS-associated FUS mutations are the Arg521Cys and Arg521Gly mutation . Although FUS inclusions are observed in about 10% of FTD patients, demonstrated pathogenic FTD mutations in the corresponding gene remain to be identified . The FET proteins FUS, EWSR1 and TAF15 share several structural and functional properties, including common J o u r n a l P r e -p r o o f tyrosine nuclear localization signal (PY-NLS) ( Figure 1 ). Besides RNA transcription and processing, FET proteins take part in RNA transport, micro-RNA processing, and DNA repair (Neumann et al., 2011) . In neurons they allow bi-directional axonal transport of mRNAs into dendritic spines, an indispensable step for neuronal maturation (Fujii and Takumi, 2005) .
The majority of FUS mutations cluster at the C-terminal NLS and RGG3 domains ( Figure 1) (Belzil et al., 2009; Chio et al., 2009; Corrado et al., 2010; Kwiatkowski et al., 2009; Ticozzi et al., 2009; Vance et al., 2009) . For TAF15 and EWSR1, some occasional missense mutations in the conserved C-terminal domains were identified in sporadic ALS patients, but strong genetic evidence for causality is presently lacking (Couthouis et al., 2012; Ticozzi et al., 2011) . Mutations affecting the NLS cause FUS mislocalization to the cytoplasm, where it accumulates into SGs (Bosco et al., 2010; Dormann et al., 2010; Kwiatkowski et al., 2009; Sama et al., 2013; Vance et al., 2013) (Figure 2 ). The PY-NLS motif acts as a binding site for the nuclear import receptor, Transportin 1, and when mutated was shown to impair Transportin -mediated nuclear import of FUS, resulting in significant cytoplasmic retention along with nuclear FUS depletion.
Importantly, it seems that the level of cytoplasmic mislocalization correlates with disease severity and age of onset (Bosco et al., 2010; Dormann et al., 2010) . The resulting cellular changes activate SGs to recruit mutant FUS (Andersson et al., 2008; Bentmann et al., 2012) , which in affected neurons increasingly aggregates into cross-beta fibrils and matures towards a solid pathological state (Murakami et al., 2015; Patel et al., 2015) . Unlike TDP-43, mutant FUS aggregation into SGs is not driven by the LCD, but rather requires the arginine-rich RGG3 domain (Baron et al., 2013; Bentmann et al., 2012; Bogaert et al., 2018; Daigle et al., 2013; Hofweber et al., 2018; Rajyaguru and Parker, 2012) . LLPS in FUS results from a complex process of intramolecular interactions between the oppositely located SYGQ-LCD and RGG3 domain. While both domains are required for nucleation, the arginine residues in the RGG3 motif largely drive FUS-self-assembly, and, as such, are the main drivers of FUS accumulations in the SGs (Bogaert et al., 2018; Hofweber et al., 2018; Yoshizawa et al., 2018) . This incorporation and maturation of mutant FUS into SGs not only alters SG dynamics, but also their morphology by increasing their size and abundance (Baron et al., 2013) . Consequently, together with the nuclear depletion of wild-type FUS, cytoplasmic FUS accumulation into SGs further sequesters wild-type FUS, indicative of a dominantnegative effect, disrupting RNA processing and ultimately leading to neurodegeneration (Vance et al., 2013) .
Manipulating FUS LLPS through Transportin 1 has been proposed as a therapeutic avenue (Hofweber et al., 2018; Yoshizawa et al., 2018) . The strong interaction between the FUS-NLS and Transportin 1 enables Transportin 1 to also bind weakly to other regions of the protein that are involved in the LLPS, Journal Pre-proof J o u r n a l P r e -p r o o f such as the LCD or RGGs. These competitive interactions may block binding sites that are required for LLPS, thereby preventing phase separation (Yoshizawa et al., 2018) . As such, treatment with Transportin 1 could mitigate both mislocalization of FUS and aberrant LLPS. Furthermore, phosphorylation of the FUS SYGQ-LCD (Monahan et al., 2017) and methylation of the arginine residues of the RGG3 domain (lost in FTD-FUS patients), were also shown to prevent LLPS and aggregation into SGs (Hofweber et al., 2018) .
II.3 hnRNPA1 and hnRNPA2B1
Combined linkage analysis and exome sequencing identified autosomal dominant missense mutations in hnRNPA2B1 and hnRNPA1 in families with multisystem proteinopathy (MSP), a group of pleiotropic degenerative disorders that variably affect muscle, bone and the nervous system, as well as in one family with classical ALS (Kim et al., 2013) . The missense mutations affected a paralogous, conserved aspartate residue in the LCD of both hnRNPA2B1 and hnRNPA1 (Kim et al., 2013) . A cosegregating hnRNPA1 mutation affecting the LCD embedded PY-NLS was also identified in a Chinese ALS family (Liu et al., 2016) . This mutation affects the essential conserved Proline residue of the C-terminal PY motif of the NLS, resulting in cytoplasmic hnRNP A1 aggregation comparable to PY-NLS mutations in FUS (Liu et al., 2016) . Yet, screening of extended cohorts of ALS, FTD and MSP for hnRNPA1 and hnRNPA2B1 failed to detect additional mutations (Le Ber et al., 2014; Seelen et al., 2014) . As such, despite strong supporting functional evidence of pathogenicity, mutation frequencies for both hnRNPA1 and hnRBNA2B1 across multiple studies are very low, estimated at <<1% in sporadic and familial ALS (Kim et al., 2013; Purice and Taylor, 2018) .
The encoded proteins hnRNP A1, hnRNP A2 and hnRNP B1 (hnRNP A2 and B1 are two isoforms transcribed from the hnRNPA2B1) are abundantly and ubiquitously expressed hnRNPs and, l ike the other members of this protein family, are involved in many aspects of RNA metabolism. Mainly present in the nucleus, a prominent function is their involvement in alternative splicing through the interaction with other hnRNPs (Huelga et al., 2012) . Furthermore, these proteins contribute to RNA synthesis and regulate mRNA processing and stabilization, and were found to directly interact with TDP -43 (Buratti et al., 2005) . HnRNP A1 and hnRNP A2/B1 have identical domain structures including two RRM domains at the N-terminus and an LCD at the C-terminus. The PY-NLS, in addition to nuclear import, also signals nuclear export of hnRNP A1 and A2/B1 to the cytoplasm, where they regulate translation (Figure 1 ).
Like the above mentioned RBPs, hnRNP A1-and A2/B1 sequester into SGs upon cellular stress, a process that is promoted by disease-causing mutations and drives cytoplasmic inclusion formation (Kim et al., J o u r n a l P r e -p r o o f Baradaran-Heravi et al., 8 2013) . Particularly, hnRNPA1-and A2/B1 harbor a steric zipper motif in the LCD that is affected by the identified mutations and which accelerates self-seeding fibril formation and cross-polymerization with wild-type protein (Kim et al., 2013) .
II.4 ATXN2
Expanded polyglutamine (polyQ) repeats ( 34 CAG repeat units in exon 1) in ataxin-2 (ATXN2) cause autosomal dominant spinocerebellar ataxia type 2 (SCA2) (Imbert et al., 1996; Sanpei et al., 1996) . Yet, ATXN2 intermediate repeats (27-33 repeat units) have been associated with an increased risk for ALS, with a frequency of about 5%, irrespective of family history (Elden et al., 2010) . ATXN2 complexes with TDP-43 in a RNA dependent manner and the polyQ expansion increases this interaction (Elden et al., 2010 ). Furthermore, ATXN2 was shown to be a potent modifier of TDP-43 toxicity (Elden et al., 2010) .
Also ATXN2 belongs to the group of RBPs and is involved in RNA metabolism. ATXN2, which under normal conditions localises to the cytoplasm, has been identified as a component of SGs where it influences SG assembly and regulation (Kaehler et al., 2012) . Indeed, a recent study demonstrated intrinsically disordered domains in ATXN2, including a prion-like domain with RNA binding function, that mediate LLPS and SG assembly (Bakthavachalu et al., 2018) ( Figure 1 ). In ALS, the polyQ expansion was shown to stabilize the interaction with TDP-43, and further promote sequestration of TDP-43 to form irreversible cytoplasmic inclusions .
II.5 TIA1
Recently, exome sequencing in a European ALS-FTD family with TDP-43 brain pathology identified a cosegregating missense mutation Pro362Leu in the LCD of yet another RBP gene, TIA1 . Subsequent gene burden analysis in a cohort of unrelated patients (ALS, FTD-ALS) and controls supported a significant association with disease, with an observed mutation frequency of ~2% fALS and <0.5% sALS . TIA1 LCD mutations were previously linked to autosomal dominant Welander distal myopathy, a muscular dystrophy also characterized by TDP-43 pathology (Hackman et al., 2013; Klar et al., 2013) . However, follow-up studies in large patients and control sets failed to replicate this disease association in ALS (van der Spek et al., 2018) and FTD (Baradaran-Heravi et al., 2018) , and observed several rare LCD variants in unaffected controls. Of interest though, is that one of those variants recurring in patients and controls, Asn357Ser, was recently associated with MSP risk when inherited digenically together with a SQSTM1 mutation, driving the myodegeneration phenotype J o u r n a l P r e -p r o o f in MSP (Lee et al., 2018) . This association between TIA1 and SQSTM1 uncovers an interesting link between impaired SG dynamics and autophagy in neuro-and myodegeneration (Lee et al., 2018) .
Despite the current lack of clear genetic replication, functional evidence for the involvement of TIA1 in ALS-FTD pathogenesis is compelling. TIA1 encodes a typical RBP with one LCD at the C-terminal site and three RRM motifs at the N-terminal site (Kedersha et al., 2000) (Figure 1 ). TIA1 is mainly localized in the nucleus, where it regulates multiple aspects of RNA metabolism including alternative splicing, translational repression, and mRNA silencing (Carrascoso et al., 2014; Lopez de Silanes et al., 2005) .
Upon cellular stress however, it redistributes to the cytoplasm where it forms SGs through selfassociation of its LCD (Gilks et al., 2004; Kedersha et al., 2000 
III. Stress granules -a pathological seeding hub of RNA-binding proteins
A common feature of FTD-ALS related RBPs is their implication in SGs, which are spherical liquid-like structures transiently formed in the cytoplasm (Figure 2 ). SG formation is initiated upon cellular stress and presents a sophisticated way for the cell to conserve energy by shifting translation towards production of essential proteins needed for survival (Molliex et al., 2015) . In eukaryotic cells, such redirection of translation is achieved by pooling of stalled non-translated mRNAs together with RBPs into highly dynamic granule structures (Kedersha et al., 2000; Kedersha et al., 1999; Lindquist, 1981) . As such, SGs represent a type of RNA-silencing foci with mRNAs and RBPs as their silencer, building a functional unit known as hnRNP granules (Morimoto, 2011) . However, SGs are more complex than just a recruitment of two components. Depending on the type of stress and the stimulated signalling pathway, several molecules involved in the translational machinery, such as polyA-RNAs or translation initiation factors, can co-localize and contribute to SG activated translation regulation. A characteristic feature of SGs is their fast and reversible assembly into membrane-less compartments with liquid-like and dynamic properties (Kedersha et al., 2013; Molliex et al., 2015; Wheeler et al., 2016) (Figure 2) . In contrast to the classical model of protein aggregation with oligomerisation of misfolded proteins into insoluble fibrils, J o u r n a l P r e -p r o o f the SG biology is reversible and tightly regulated. This is important to quickly dissolve and release proteins required for translation after the stress subsides.
The mechanism of how membrane-less SG assemble is based on biochemical processes that enables the transition of molecules from soluble to liquid-like forms, known as LLPS (Molliex et al., 2015) . The exact molecular mechanisms of LLPS remains elusive, but is attributed to the thermodynamic movement of a complex to seek the lowest energy state. In cells this means that a homogenous cytoplasm becomes oversaturated upon increased protein concentration and decomposes into two co-existing soluble and liquid phases (Shin and Brangwynne, 2017) . LLPS requires RBPs that bind to nascent mRNAs via their conservative RNA-recognition motifs (RRM) (Shin and Brangwynne, 2017) (Figure 2 ). This primary RNP nucleation builds a stable core as the basis for a secondary maturation recruiting further RBPs that form a dynamic shell around the core (Wheeler et al., 2016) . The core-shell architecture of SGs is not only based on RNA interaction but also initiated upon protein-protein interaction promoted by intrinsically unfolded LCDs present in RBPs. A prominent function of LCDs is the modulation of reversible binding to both proteins and RNA to trap them into granules (Figure 2) . The multivalent interaction of LCDs presents an essential impetus for RBPs to nucleate. Additionally, also RNA molecules appear to be a determining component in the SG composition (Boeynaems et al., 2019; Maharana et al., 2018; Mann et al., 2019) . They regulate nucleation and promote LLPS through intermolecular RNA-RNA interactions (Khong et al., 2017; Langdon et al., 2018; Van Treeck et al., 2018) . Furthermore, there is growing evidence that RNA regulates SG biology in a concentration-dependent manner. Low RNA concentration relative to the protein promotes LLPS of RBPs (Molliex et al., 2015) , whereas a high RNA:protein ratio prevents nucleation (Maharana et al., 2018) . As such, it seems that cytoplasmic RNA promotes LLPS just up to the point where high local RNA levels inside the SGs prevent excessive aggregation and thereby maintains SG dynamics. This inhibitory effect of RNA on LLPS can be attributed to competitive binding of RNA to RRM and LCD regions that normally present recognition sites for self-assembly Protter et al., 2018; Yoshizawa et al., 2018) . Given that the cytoplasm has low RNA:protein ratio compared to the nucleus (Maharana et al., 2018) , this regulation is important, as it provides a mechanism that assures a soluble state of RBPs in the nucleus. Taken together, it seems that SG formation is a complex, multi-layered process that is driven by dynamic RBP-RNA, RBP-RBP and RNA- (Conicella et al., 2016; Mackenzie et al., 2017; Patel et al., 2015) . In turn, NLS mutations increase the cytoplasmic concentration of the protein. In both cases, this shift forms a starting point of a pathological cascade that stimulates mutated proteins to aggregate into toxic insoluble protein aggregations and consequently disrupts the protein equilibrium (Patel et al., 2015) . As a result, RBP hyperaggregation causes stress to the cell, which induces the formation and maturation of SGs. This way, SGs can grow and act as hubs for further recruitment of additional RBPs, such as TDP-43 ( Figure 2) .
Recent evidence suggests that RNA binding is a prerequisite for the recruitment of TDP -43 to SGs (Daigle et al., 2013; Mann et al., 2019) . In moderation, SGs are beneficial as they prevent the neurons from further neurodegeneration by sequestering toxic protein aggregates, but, an over-active SG response will also trap functional RBPs resulting in a deleterious degenerative effect (Figure 2 ). This is consistent with the co-localization of FTD-ALS related RBPs to SGs as has been observed in pathological brain tissues. The presence of increased aggregates turns the normally reversible SGs into insoluble inclusions that cannot disassemble, even after stress stimuli subside. As such, RBPs recruited by SGs cannot be released to perform their function in essential pathways. Furthermore, the increased recruitment of RBPs with associated RNA species changes the pool of the cellular transcriptome available for translation. Therefore, the persistent SGs not only impair proteostasis, but also alter RNA homeostasis (ribostasis) and protein synthesis (Kedersha et al., 2000; Kedersha et al., 1999; Ramaswami et al., 2013) , further deregulating neuronal pathways. Overall, SG pathology upon mutated LCDs or NLSs of RBPs comprises a series of pathomechanisms leading to neuronal impairment. These include hyperaggregation of mutated SG-associated RBPs, disrupted SG dynamics with persistence of pathological SGs and defective SG clearance. Furthermore, persistent SGs can interfere with other pathways by capturing various functional proteins and mRNAs. For example, SGs can trap proteins involved in the nucleocytoplasmic transport leading to nuclear import deficits of RBPs causing increased cytoplasmic concentration . Since LLPS is a concentration-dependent process, the increased RBP levels in the cytoplasm further provoke protein aggregation into SGs. Different groups have recently deepened our insight into SG biology and its link to toxic protein aggregation (Gasset-Rosa et al., 2019; Mann et al., 2019; McGurk et al., 2018; Zhang et al., 2019) . While these studies are consistent regarding the initial recruitment of TDP-43 to SGs upon sufficient cellular stress (Ayala et al., 2011; Colombrita et al., 2009; Dewey et al., 2011; Freibaum et al., 2010; Liu-Yesucevitz et al., 2010; McDonald et al., 2011; Meyerowitz et al., 2011) , they propose different pathways leading to toxic protein aggregation (Figure 2 ). Of note, exposing cells to variable stress Depending on the type of stress stimulus, there are alternative models for the formation of such toxic TDP-43 granules. One model involves conventional SGs, using them as sites for maturation of insoluble RBP aggregates that dissociate from SG components and are able to disassemble over time, leaving behind insoluble FTD-ALS protein aggregates (Figure 2) . Alternatively, insoluble toxic aggregates can form independent of SGs ( Figure 2) . These alternate pathways are based on recent data demonstrating the presence of stress-induced TDP-43 droplets inside as well as outside of SGs, whereby the toxicity is rather attributed to the insoluble fraction outside SGs. Upon stress, TDP-43 initially co-localizes to the SGs where it is protected from hyperphosphorylation and excessive aggregation by the higher RNA load.
Under chronic stress, however, when RBPs linger too long in the SGs, the conditions inside the SG promote their maturation into insoluble aggregates that in turn impair SG dynamics. Eventually these impacts on the SGs convert them into persistent granules that seed further protein aggregation and culminate into insoluble toxic aggregates (Figure 2 ).
IV. C9orf72 and SG biology
In 2011, the discovery of a non-coding hexanucleotide repeat expansion (GGGGCC) mutation in the C9orf72 gene drastically shifted the FTD-ALS field Gijselinck et al., 2012; Renton et al., 2011) , with up to 40% of fALS patients carrying such a repeat expansion, 25% of familial FTD and a staggering 88% of familial patients with both ALS and FTD (Cruts et al., 2013; Van Mossevelde et al., 2017a) . The contribution of C9orf72 is also significant in isolated patients without clear family history explaining 5-10% of sporadic cases, indicative of its incomplete penetrance. The GGGGCC (G 4 C 2 ) expansion is located in the 5'UTR of the C9orf72 gene, in the intronic region between alternative exons 1a and 1b, and is highly polymorphic. The cut-off to distinguish normal from pathogenic expansions remains somewhat ambiguous. In general, in unaffected individuals repeat sizes vary from 2 to 24 repeat units, whereas in patients the repeat expands from several hundreds to several J o u r n a l P r e -p r o o f thousand repeats. The smallest repeat with evidence of cosegregation with disease was 50 re peat units (Gijselinck et al., 2016) . Although, no clear anticipation was described in initial studies, recent reports provide molecular and clinical evidence supporting anticipation, demonstrating increased methylation of the expanded promoter repeat and upstream CpG island, and earlier disease onset towards younger generations, both correlated with increasing repeat size (Gijselinck et al., 2016; Van Mossevelde et al., 2017b) .
Although C9orf72 is not an RBP, recent evidence demonstrates that C9orf72 and its repeat are also implicated in SG-mediated toxic protein aggregation and perturbed RNA metabolism. In addition to the TDP-43 pathology, a distinctive feature of C9orf72 mutation carriers is the presence of neuronal inclusions that are negative for TDP-43, but positive for p62 and dipeptide repeat proteins (DPRs) (Mackenzie et al., 2013) . DPRs are generated upon unconventional bidirectional translation of the expanded repeat RNA via a mechanism called repeat-associated non-AUG (RAN) translation (Ash et al., 2013; Mori et al., 2013a; Mori et al., 2013b; Zu et al., 2011; Zu et al., 2013) . This generates five distinct DPRs; poly glycine-alanine (GA) and glycine-arginine (GR) are generated from the sense strand, poly proline-arginine (PR) and proline-alanine (PA) from the antisense, and glycine-proline (GP) from both sense and antisense transcripts (Mori et al., 2013) . These DPRs are prone to self-aggregation and form toxic protein aggregates in the brain and spinal cord of C9orf72-related FTD-ALS patients. Neuronal expression revealed highest toxicity for the positively charged arginine-rich DPRs, poly-GR and poly-PR, modest toxicity for poly-GA and no toxicity for poly-GP and poly-PA DPRs (Kwon et al., 2014) . Similar to glycine-or arginine-rich LCDs in RBPs that are prone to LLPS, the arginine-rich DPRs interfere with the dynamic assembly and disassembly of SGs by the formation of strong interactions with the LCDs of RBPs in these granules, perturbing phase transitions mediated by the normally weak and transient interactions of the LCDs (Boeynaems et al., 2017; Lee et al., 2016) (Figure 2 ). In line with this, the arginine content and consequently the repeat sizes of DPRs correlate with the intensity of nucleation.
Although demonstrated to be less toxic, poly-GA expression in primary neurons diminishes dendritic branching, induces caspase-3 mediated apoptosis, inhibits proteasome activity, thereby inducing endoplasmatic reticulum (ER) stress (Mizielinska et al., 2014; Wen et al., 2014) . In response to this prolonged ER stress, cells activate the ER stress response pathway as part of the integrated stress response (ISR), leading to SG formation. A key step in the ISR pathway is the phosphorylation of the translation initiation factor, eIF2α (p-eIF2α). Interestingly, p-eIF2α is also required for SG formation and enhances C9orf72 derived RAN-translation (Cheng et al., 2018; Green et al., 2017; Sonobe et al., 2018; Westergard et al., 2019) . As such, p-eIF2α represents an intersection point of these pathways. The complex interplay between RAN translation and SG formation suggest a feed forward loop, where both processes induce each other in a p-eIF2α dependent manner (Hartmann et al., 2018) (Figure 2 ).
In addition to the toxic DPR aggregates, another characteristic feature of C9orf72 pathology is the accumulation of nuclear and cytoplasmic RNA foci Mizielinska et al., 2013; Zu et al., 2013) . Although RNA foci contain both sense (G 4 C 2 ) and antisense (C 4 G 2 ) repeat RNA, their formation is only based on the sense repeat RNA, which can self-assemble through non-canonical RNA base pairing between contiguous guanines stretches into G-quadruplexes (G-Q structures) (Gendron et al., 2013a; Zu et al., 2013) . There is some evidence that cytoplasmic RNA-foci can be classified as actual SGs as they are positive for conventional SG markers and show similar behaviour in their dynamics (Fay et al., 2017) . Therefore the repeat RNA not only promotes, but also contributes to the formation of both cytoplasmic SGs and nuclear RNA foci (Donnelly et al., 2013; Fay et al., 2017) . The expanded repeat RNA seeds nucleation in a repeat-length dependent manner, as long RNA molecules can self-aggregate with higher efficiency (Fay et al., 2017; Jain and Vale, 2017) . The higher order G-Q structures of long G 4 C 2 repeat RNA provides new surface to recruit additional RBPs and toxic DPRs, enhancing RNA nucleation into toxic RNA/SG inclusions (Fay et al., 2017) . Consequently, analogous to conventional SGs, nuclear and cytoplasmic RNA foci sequester RNAs as well as RBPs and induce a pathogenic cascade including defective RNA splicing and RNA metabolism (Donnelly et al., 2013; Gijselinck et al., 2012; Mori et al., 2013b) (Figure 2 ).
Finally, also wild-type C9orf72 appears to play a role in SG assembly, where loss of C9orf72 abolishes SG formation and thereby compromises cellular stress recovery response and survival (Maharjan et al., 2017) .
Taken together, previous and recent research suggests an intricate interplay of both gain and loss of function mechanisms in C9orf72 pathogenesis, where the (G 4 C 2 ) hexanucleotide expansion causes disease through formation of toxic RNA foci and DPR aggregates, causing chronic tress to the cell leading to SG formation. In turn, the DPRs and RNA foci further interfere with the dynamic disassembly of the SGs. Furthermore, stress recovery responses are compromised by the loss of C9orf72.
VI. Concluding remarks
Impaired proteostasis and toxic protein aggregation is a common pathological feature that unites many neurodegenerative disorders, including FTD and ALS. A better understanding of molecular mechanisms underlying this protein imbalance may aid our understanding of the FTD-ALS disease biology and identify J o u r n a l P r e -p r o o f novel therapeutic targets. In this review, we surveyed SG-related RBPs that play a role in the deposition of defective protein in affected neurons. Mounting evidence independently demonstrates that toxic protein aggregation is often driven by changes in the LCDs of RBPs, resulting in an increased tendency towards LLPS and SG formation. Over 250 human proteins are predicted to harbor LCDs, many of which are RBPs (Kim et al., 2013) . What's more, several of these proteins have already been identified in FTD-ALS related SGs, some of which have not yet been genetically linked to disease. These should be considered candidate genes and offer opportunities for gene prioritization when mining large-scale sequencing data of unresolved FTD and ALS.
The loss of SG dynamics seeding persistent toxic protein inclusions suggest defective protein clearance mechanisms. In that context it is of interest that the valosin-containing protein (VCP) -when mutated linked to FTD, ALS and myopathy -has been demonstrated to be a key mediator in the autophagic clearance of SGs (Buchan et al., 2013) . Likely, culmination of multiple pathological cascades, including a.o. hyper-aggregation of mutated SG-associated RBPs and failure of SG clearance by impaired autophagy are at play. Stimulation of the autophagy pathway, together with finding ways to control phase separation and ephemeral SG formation, may offer opportunities for synergistic therapeutic approaches to reverse pathological protein aggregation and protect against toxicity. One therapeutic strategy could involve the synthesis of antisense single stranded oligonucleotides (ASO) that bind the target RNAs to make them inaccessible for RBPs. ASOs are appealing, because they can be intrathecally injected to reach the central nervous system. Such dosage-reduction approaches have already proven successful in mouse models, where knock down of RBPs such as ATXN2 radically delayed disease progression and resulted in a milder phenotype (Becker et al., 2017) . Furthermore, targeting RRM domains of RBPs using specific RNA bait oligonucleotides has been recently proposed. Given that RNA binding can inhibit LCD interaction between RBPs, specific oligonucleotides with high affinity to the RRM domains of TDP-43 could antagonize aberrant LLPS phase separation and alleviate neurotoxic effects (Mann et al., 2019) . In tauopathies, mutant tau was shown to strongly interact with the primary SG component TIA1. In a bidirectional manner, TIA1 traps phospho-tau into SGs, where the local environment further contributes to the stabilization of tau and accelerates its maturation into insoluble fibrils. In turn, phospho-tau regulates the interaction of TIA1 with other RBPS (Apicco et al., 2018; Vanderweyde et al., 2016; Vanderweyde et al., 2012) . This tau-TIA1 complex inside the SGs was demonstrated to cause tau-mediated degeneration in cultured neurons, which could be rescued by knockout of TIA1, indicating that targeting TIA1 could be a potent molecular target to tackle tauopathies (Vanderweyde et al., 2016) .
J o u r n a l P r e -p r o o f
It remains striking that, although the FTD-ALS related genes discussed in this review are ubiquitously expressed, the central nervous system (CNS) appears to be particularly vulnerable to these changes in RBP and SG biology. One explanation may be the role of RBPs in alternative splicing, which is exceptionally high in CNS neurons (Yeo et al., 2004) . Consequently, larger amounts of generated isoforms likely need more refined regulation, and as such neurons may be more sensitive to proper RBP function than other cell types. Furthermore, RBPs are involved in the transport of mRNAs and SGs along the axons, which are the longest in motor neurons, making them particularly susceptible to axonal trafficking deficits. Despite the immense progress that has been made in understanding the mechanisms of over-active SGs and protein aggregation in FTD-ALS, it remains unclear whether the neurodegeneration is attributed to gain of toxic function caused by the SGs, or rather, loss of function of the trapped proteins. Likely, it is a combination of both. The systematic co-localization of TDP-43 suggests that these defective SGs act as TDP-43 traps. Yet, whether SG-mediated toxic protein aggregation presents cause or consequence of disease remains to be further elucidated.
SGs are initially beneficial, however, upon prolonged stress, SGs either evolve into toxic aggregates (Zhang et al., 2019) or present sites of growth of insoluble aggregates that persist after SG disassembly (Mann et al., 2019; McGurk et al., 2018) . In addition, other toxic stress-induced aggregates may form, Mutations were extracted from the ALS data browser http://alsdb.org, the online genetic ALS database http://alsod.iop.kcl.ac.uk, (Albrecht et al., 2004; Baradaran-Heravi et al., 2018; Belzil et al., 2011; Belzil et al., 2009; Benajiba et al., 2009; Blair et al., 2010; Borroni et al., 2010; Borroni et al., 2009; Broustal et al., 2010; Buratti, 2015; Cady et al., 2015; Chiang et al., 2012; Chio et al., 2010; Cirulli et al., 2015; Corrado et al., 2010; Couthouis et al., 2012; Couthouis et al., 2014; Groen et al., 2010; Hewitt et al., 2010; Huey et al., 2012; Ju et al., 2011; King et al., 2012; Kovacs et al., 2009; Kumar et al., 2008; Kwiatkowski et al., 2009; Lagier-Tourenne et al., 2010; Lattante et al., 2013; Lee et al., 2006; Lek et al., 2016; Marko et al., 2012; Millecamps et al., 2010; Moreno et al., 2015; Neumann et al., 2011; Quadri et al., 2011; Rademakers et al., 2010; Segal et al., 2006; Soong et al., 2014; Ticozzi et al., 2009; Ticozzi et al., 2011; Van Langenhove et al., 2010; Winton et al., 2008b; Yan et al., 2010; Zakaryan and Gehring, 2006 with liquid-like properties, yet can serve as sites for mutant proteins to increasingly aggregate through overactive liquid-liquid phase separation (LLPS) into solid pathological granules (1). These solid aggregates will convert over time into persistent SG-related protein aggregates, also trapping wild-type protein along its path (2). Alternatively, they can demix over time from the SG components into distinct insoluble RBP aggregates (toxic protein inclusion) (3) (Mann et al., 2019; McGurk et al., 2018; Zhang et al., 2019) . C9orf72-derived cytoplasmic RNA-foci can sequester RBPs (4). In turn, arginine-rich DPRs tend to bind to the LCDs of RBPs, reinforcing the protein-protein interactions within the SG and perturbing J o u r n a l P r e -p r o o f phase transition, further promoting aggregation of disease-related proteins (5) (Boeynaems et al., 2017; Lee et al., 2016) . Finally, poly-GA DPRs induce endoplasmatic reticulum (ER) stress as part of the integrated stress response (ISR), causing phosphorylation of the translation initiation factor, eIF2α (p -eIF2α), which stimulates SG formation and further enhances RAN-translation, maintaining a condition of persistent stress (6) (Cheng et al., 2018; Green et al., 2017; Sonobe et al., 2018; Westergard et al., 2019) .
Orange section -Model for SG-independent protein aggregation of mutant RBPs. Increased cytoplasmic concentration of mutant RBPs triggers LLPS into disease -related aggregates independent of conventional SGs, also trapping other essential proteins (7) (Chen and Cohen, 2019; Gasset-Rosa et al., 2019) . 
